{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:15:02Z","timestamp":1791321302616,"version":"4.3.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"crossref","award":["2011.085.1\/2"],"award-info":[{"award-number":["2011.085.1\/2"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002745","name":"Bayerische Forschungsstiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002745","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["I1\/M.M.-C.H"],"award-info":[{"award-number":["I1\/M.M.-C.H"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB796\/C3"],"award-info":[{"award-number":["SFB796\/C3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["MA 1289\/7-1"],"award-info":[{"award-number":["MA 1289\/7-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.antiviral.2015.10.003","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T04:13:40Z","timestamp":1446696820000},"page":"101-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"special_numbering":"C","title":["The broad-spectrum antiinfective drug artesunate interferes with the\u00a0canonical nuclear factor kappa B (NF-\u03baB) pathway by targeting RelA\/p65"],"prefix":"10.1016","volume":"124","author":[{"given":"Corina","family":"Hutterer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina","family":"Niemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Milbradt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Fr\u00f6hlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onat","family":"Kadioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanife","family":"Bahsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Zeittr\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Einsiedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gmeiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nico","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Wandinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Godl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Stamminger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Efferth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana B.","family":"Tsogoeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Marschall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2015.10.003_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/j.semperi.2007.01.002","article-title":"Recent advances in the prevention and treatment of congenital cytomegalovirus infections","volume":"31","author":"Adler","year":"2007","journal-title":"Semin. Perinatol."},{"key":"10.1016\/j.antiviral.2015.10.003_bib2","doi-asserted-by":"crossref","first-page":"e10370","DOI":"10.1371\/journal.pone.0010370","article-title":"Artemisinin-derived dimers have greatly improved anti-cytomegalovirus activity compared to artemisinin monomers","volume":"5","author":"Arav-Boger","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2015.10.003_bib3","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jviromet.2011.03.005","article-title":"A\u00a0reporter system for Epstein-Barr virus (EBV) lytic replication: anti-EBV activity of the broad anti-herpesviral drug artesunate","volume":"173","author":"Auerochs","year":"2011","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.antiviral.2015.10.003_bib4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1128\/JVI.78.2.741-750.2004","article-title":"Neutrality of the canonical NF-kappaB-dependent pathway for human and murine cytomegalovirus transcription and replication in\u00a0vitro","volume":"78","author":"Benedict","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2015.10.003_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0014-5793(96)01502-5","article-title":"Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF-\u03baB","volume":"402","author":"Bork","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.antiviral.2015.10.003_bib6","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/AAC.01972-13","article-title":"In\u00a0vitro combination of anti-cytomegalovirus compounds acting through different targets: role of the slope parameter and insights into mechanisms of Action","volume":"58","author":"Cai","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.10.003_bib7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.antiviral.2011.07.018","article-title":"The unique antiviral activity of artesunate is broadly effective against human cytomegaloviruses including therapy-resistant mutants","volume":"92","author":"Chou","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2015.10.003_bib8","doi-asserted-by":"crossref","first-page":"50010","DOI":"10.1074\/jbc.M306530200","article-title":"Constitutive signaling of the human cytomegalovirus-encoded receptor UL33 differs from that of its rat cytomegalovirus homolog R33 by promiscuous activation of G proteins of the Gq, Gi, and Gs classes","volume":"278","author":"Casarosa","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2015.10.003_bib9","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.virol.2005.09.065","article-title":"Prolonged activation of NF-kappaB by human cytomegalovirus promotes efficient viral replication and late gene expression","volume":"346","author":"DeMeritt","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.10.003_bib10","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/clpt.2010.178","article-title":"Update on new antivirals under development for the treatment of double-stranded DNA virus infections","volume":"88","author":"Dropulic","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2015.10.003_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00109-001-0300-8","article-title":"Antiviral activity of artesunate towards wild-type, recombinant and ganciclovir-resistant human cytomegaloviruses","volume":"80","author":"Efferth","year":"2002","journal-title":"J.\u00a0Mol. Med."},{"key":"10.1016\/j.antiviral.2015.10.003_bib12","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.freeradbiomed.2004.06.023","article-title":"Enhancement of cytotoxicity of artemisinins towards cancer cells by ferrous iron","volume":"37","author":"Efferth","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.antiviral.2015.10.003_bib13","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/591195","article-title":"The antiviral activities of artemisinin and artesunate","volume":"47","author":"Efferth","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.10.003_bib14","doi-asserted-by":"crossref","first-page":"9642","DOI":"10.1074\/jbc.M312893200","article-title":"RICK activates a NF-kappaB-dependent anti-human cytomegalovirus response","volume":"279","author":"Eickhoff","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2015.10.003_bib15","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1099\/vir.0.030494-0","article-title":"Recruitment of cyclin-dependent kinase 9 to nuclear compartments during cytomegalovirus late replication: importance of an interaction between viral pUL69 and cyclin T1","volume":"92","author":"Feichtinger","year":"2011","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.10.003_bib16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/jac\/dkt346","article-title":"Stability and antiviral activity against human cytomegalovirus of artemisinin derivatives","volume":"69","author":"Flobinus","year":"2014","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2015.10.003_bib17","doi-asserted-by":"crossref","first-page":"39713","DOI":"10.1074\/jbc.M101985200","article-title":"Cysteine 38 in p65\/NF-kappaB plays a crucial role in DNA binding inhibition by sesquiterpene lactones","volume":"276","author":"Garcia-Pineres","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2015.10.003_bib18","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.lfs.2004.01.024","article-title":"Role of cysteine residues of p65\/NF-kappaB on the inhibition by the sesquiterpene lactone parthenolide and N-ethyl maleimide, and on its transactivating potential","volume":"75","author":"Garcia-Pineres","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.antiviral.2015.10.003_bib19","doi-asserted-by":"crossref","first-page":"7048","DOI":"10.1128\/JVI.71.9.7048-7060.1997","article-title":"The UL84 protein of human cytomegalovirus acts as a transdominant inhibitor of immediate-early-mediated transactivation that is able to prevent viral replication","volume":"71","author":"Gebert","year":"1997","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2015.10.003_bib20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.antiviral.2013.10.014","article-title":"Success and failure of artesunate treatment in five transplant recipients with disease caused by drug-resistant cytomegalovirus","volume":"101","author":"Germi","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2015.10.003_bib21","doi-asserted-by":"crossref","first-page":"e24334","DOI":"10.1371\/journal.pone.0024334","article-title":"An artemisinin-derived dimer has highly potent anti-cytomegalovirus (CMV) and anti-cancer activities","volume":"6","author":"He","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2015.10.003_bib22","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1128\/AAC.00519-12","article-title":"Artemisinin-derived dimer diphenyl phosphate is an irreversible inhibitor of human cytomegalovirus replication","volume":"56","author":"He","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.10.003_bib23","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1128\/AAC.00893-13","article-title":"Unique and highly selective anticytomegalovirus activities of artemisinin-derived dimer diphenyl phosphate stem from combination of dimer unit and a diphenyl phosphate moiety","volume":"57","author":"He","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.10.003_bib24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pharmthera.2013.12.001","article-title":"Artemisinins: pharmacological actions beyond anti-malarial","volume":"142","author":"Ho","year":"2014","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.antiviral.2015.10.003_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.antiviral.2013.04.017","article-title":"Profiling of the kinome of cytomegalovirus-infected cells reveals the functional importance of host kinases Aurora A, ABL and AMPK","volume":"99","author":"Hutterer","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2015.10.003_bib26","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1128\/AAC.04534-14","article-title":"A\u00a0novel CDK7 inhibitor of the pyrazolo-triazine class exerts broad-spectrum antiviral activity at nanomolar concentrations","volume":"59","author":"Hutterer","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.10.003_bib27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.antiviral.2005.10.003","article-title":"The anti-malaria drug artesunate inhibits replication of cytomegalovirus in\u00a0vitro and in\u00a0vivo","volume":"69","author":"Kaptein","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2015.10.003_bib28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/cid\/ciq050","article-title":"Artesunate is ineffective in controlling valganciclovir-resistant cytomegalovirus infection","volume":"52","author":"Lau","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.10.003_bib29","doi-asserted-by":"crossref","first-page":"33508","DOI":"10.1074\/jbc.273.50.33508","article-title":"The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65","volume":"273","author":"Lyss","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2015.10.003_bib30","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1128\/AAC.44.6.1588-1597.2000","article-title":"Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents","volume":"44","author":"Marschall","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.10.003_bib31","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1128\/AAC.05908-11","article-title":"In\u00a0vitro evaluation of the activities of the novel anticytomegalovirus compound AIC246 (letermovir) against herpesviruses and other human pathogenic viruses","volume":"56","author":"Marschall","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.10.003_bib32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jcv.2009.05.017","article-title":"Sensitivity of human herpesvirus 6 towards the broad-spectrum antiinfective drug artesunate","volume":"46","author":"Milbradt","year":"2009","journal-title":"J.\u00a0Clin. Virol."},{"key":"10.1016\/j.antiviral.2015.10.003_bib33","series-title":"Fields Virology","article-title":"Cytomegaloviruses","author":"Mocarski","year":"2013"},{"key":"10.1016\/j.antiviral.2015.10.003_bib35","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ni.2065","article-title":"Crosstalk in NF-\u03baB signaling pathways","volume":"12","author":"Oeckinghaus","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.antiviral.2015.10.003_bib36","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/viro.1995.1143","article-title":"Stimulation of the human cytomegalovirus IE enhancer\/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB","volume":"208","author":"Pr\u00f6sch","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2015.10.003_bib37","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.antiviral.2006.06.004","article-title":"Antiviral activity of arthrospira-derived spirulan-like substances","volume":"7","author":"Rechter","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2015.10.003_bib38","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejmech.2015.04.053","article-title":"New efficient artemisinin derived agents against human leukemia cells, human cytomegalovirus and Plasmodium falciparum: 2nd generation 1,2,4-trioxane-ferrocene hybrids","volume":"97","author":"Reiter","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.antiviral.2015.10.003_bib39","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1016\/j.bmc.2015.07.048","article-title":"Highly potent artemisinin-derived dimers and trimers: synthesis and evaluation of their antimalarial, antileukemia and antiviral activities","volume":"23","author":"Reiter","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.antiviral.2015.10.003_bib40","doi-asserted-by":"crossref","first-page":"3870","DOI":"10.1128\/AAC.00262-15","article-title":"Inhibition of human cytomegalovirus replication by artemisinins: effects mediated through cell cycle modulation","volume":"59","author":"Roy","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.10.003_bib41","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1086\/587106","article-title":"Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation","volume":"46","author":"Shapira","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2015.10.003_bib42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1128\/AAC.01800-13","article-title":"Antiviral effects of artesunate on polyomavirus BK replication in primary human kidney cells","volume":"58","author":"Sharma","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.10.003_bib43","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.1128\/AAC.03714-14","article-title":"Antiviral effects of artesunate on JC polyomavirus replication in COS-7 cells","volume":"58","author":"Sharma","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2015.10.003_bib44","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1021\/jm049937r","article-title":"Quantitative structure-activity relationship of sesquiterpene lactones as inhibitors of the transcription factor NF-kappaB","volume":"47","author":"Siedle","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2015.10.003_bib45","first-page":"679090","article-title":"Artesunate exerts a direct effect on endothelial cell activation and NF-\u03baB translocation in a mechanism independent of Plasmodium killing","volume":"2012","author":"Souza","year":"2012","journal-title":"Malar. Res. Treat."},{"key":"10.1016\/j.antiviral.2015.10.003_bib46","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00430-015-0411-4","article-title":"Human cytomegalovirus: taking the strain","volume":"204","author":"Wilkinson","year":"2015","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.antiviral.2015.10.003_bib47","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.antiviral.2011.03.184","article-title":"Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation","volume":"90","author":"Wolf","year":"2011","journal-title":"Antivir. Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215300085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215300085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T23:41:20Z","timestamp":1599781280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354215300085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":46,"alternative-id":["S0166354215300085"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.10.003","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The broad-spectrum antiinfective drug artesunate interferes with the\u00a0canonical nuclear factor kappa B (NF-\u03baB) pathway by targeting RelA\/p65","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}